MX9203751A - Compuestos de arilo disubstituido que exhiben actividad antagonista selectiva de leucotrieno b4. - Google Patents

Compuestos de arilo disubstituido que exhiben actividad antagonista selectiva de leucotrieno b4.

Info

Publication number
MX9203751A
MX9203751A MX9203751A MX9203751A MX9203751A MX 9203751 A MX9203751 A MX 9203751A MX 9203751 A MX9203751 A MX 9203751A MX 9203751 A MX9203751 A MX 9203751A MX 9203751 A MX9203751 A MX 9203751A
Authority
MX
Mexico
Prior art keywords
leucotrene
antagonist activity
aryl compounds
selective antagonist
disubstituted aryl
Prior art date
Application number
MX9203751A
Other languages
English (en)
Inventor
Huang Fu-Chin
Wan K Chan
Charles A Sutherland
Galemmo Robert Anthony Jr
Michael N Chang
Original Assignee
Rhone Poulenc Rorer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Int filed Critical Rhone Poulenc Rorer Int
Publication of MX9203751A publication Critical patent/MX9203751A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9203751A 1990-09-24 1992-06-29 Compuestos de arilo disubstituido que exhiben actividad antagonista selectiva de leucotrieno b4. MX9203751A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/586,830 US5210208A (en) 1990-09-24 1990-09-24 Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity

Publications (1)

Publication Number Publication Date
MX9203751A true MX9203751A (es) 1992-09-01

Family

ID=24347270

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203751A MX9203751A (es) 1990-09-24 1992-06-29 Compuestos de arilo disubstituido que exhiben actividad antagonista selectiva de leucotrieno b4.

Country Status (9)

Country Link
US (1) US5210208A (es)
EP (1) EP0554313B1 (es)
JP (1) JP3368565B2 (es)
AT (1) ATE126205T1 (es)
AU (1) AU650825B2 (es)
CA (1) CA2092306C (es)
DE (1) DE69112074T2 (es)
MX (1) MX9203751A (es)
WO (1) WO1992005145A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3334087B2 (ja) * 1990-09-10 2002-10-15 アヴェンティス ファーマシューティカルズ インコーポレイテッド 選択的ロイコトリエンｂ▲４▼拮抗剤活性を示す置換された二環式アリール化合物
JPH0741421A (ja) * 1993-05-28 1995-02-10 Suntory Ltd ロイコトリエンｂ４ （ｌｔｂ４ ）による医学的症状の予防及び改善剤
FR2705959B1 (fr) * 1993-06-01 1995-08-11 Oreal Procédé de synthèse stéréospécifique de leucotriène B4 sous sa configuration 6Z, 8E, 10E et produits intermédiaires.
EP0833664A1 (en) 1995-06-12 1998-04-08 G.D. SEARLE & CO. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations
AU2250097A (en) * 1996-02-13 1997-09-02 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist
EP0942903A1 (en) 1996-09-26 1999-09-22 Novartis AG Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
SE0104334D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
GB0314079D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0229931D0 (en) * 2002-12-21 2003-01-29 Astrazeneca Ab Therapeutic agents
JP5148610B2 (ja) 2006-07-24 2013-02-20 ビーエーエスエフ ソシエタス・ヨーロピア アゾリルメチルオキシラン、植物病原菌類を防除するためのその使用、およびそれを含む薬剤
WO2008012234A2 (de) 2006-07-25 2008-01-31 Basf Se Azolylmethyloxirane, ihre verwendung zur bekämpfung von pflanzenpathogenen pilzen sowie sie enthaltende mittel
US7994340B2 (en) 2006-12-22 2011-08-09 Basf Se Azolylmethyloxiranes, their use for controlling phytopathogenic fungi, and compositions comprising them
US9079880B2 (en) 2010-07-07 2015-07-14 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
US8697911B2 (en) 2010-07-07 2014-04-15 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
EP2630144B1 (en) 2010-10-19 2016-09-07 Boehringer Ingelheim International GmbH Rho kinase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191824A (en) * 1976-02-04 1980-03-04 The Upjohn Company 5-Halo PGI compounds
US4216238A (en) * 1979-02-13 1980-08-05 Stauffer Chemical Company Dialkyl amino ethyl amides, their salts and their use as anti-ripening agents
US4727180A (en) * 1979-07-26 1988-02-23 E. I. Du Pont De Nemours And Company Antihypertensive polyhalohydroxylisopropyl phenylalkanoic and phenylalkenoic acids, amides and esters and intermediates thereto
US5140046A (en) * 1985-04-03 1992-08-18 Yamanouchi Pharmaceutical Co., Ltd. Phenylene derivatives, compositions and use
US4820722A (en) * 1987-08-14 1989-04-11 Eli Lilly And Company Disubstituted tetrazoles and their use as leukotriene antagonists

Also Published As

Publication number Publication date
CA2092306C (en) 2004-11-16
JPH06502164A (ja) 1994-03-10
EP0554313B1 (en) 1995-08-09
EP0554313A4 (en) 1994-05-18
US5210208A (en) 1993-05-11
JP3368565B2 (ja) 2003-01-20
CA2092306A1 (en) 1992-03-25
EP0554313A1 (en) 1993-08-11
DE69112074D1 (de) 1995-09-14
AU8761091A (en) 1992-04-15
ATE126205T1 (de) 1995-08-15
AU650825B2 (en) 1994-06-30
DE69112074T2 (de) 1996-01-11
WO1992005145A1 (en) 1992-04-02

Similar Documents

Publication Publication Date Title
MX9203751A (es) Compuestos de arilo disubstituido que exhiben actividad antagonista selectiva de leucotrieno b4.
ATE235906T1 (de) Substituierte phenylpyrimidine derivate, für die behandlung oder prevention von zns-erkrankungen
IT9020055A0 (it) Metodo per il mascheramento del sapore di farmaci
NO904694D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
KR920701466A (ko) 면역조절 장애 치료를 위한 제약학적 생성물
FR2387220A1 (fr) Derives du benzimidazole et medicaments qui en contiennent
NL970023I1 (nl) Medicamenten voor behandeling van oogontsteking.
DE68907423D1 (de) Behandlung der akne.
FI953899A (fi) Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi
EP0538416A4 (en) Substituted monocyclic aryl compounds exhibiting selective leukotriene b 4? antagonist activity
NO864130L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater.
NO883122L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
ES2058343T3 (es) Piridinas disubstituidas.
FI891986A (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
NO892505D0 (no) Behandling av vandige dispersjoner.
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DE3770718D1 (de) P-hydroxyzimtamid derivate und diese enthaltende melanininhibitoren.
DK229984D0 (da) 4-oxothiazolidin-2-yliden-acetamid-derivater
NO905327D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamoylderivater.
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
IT8619382A0 (it) Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
DK382A (da) Antiallergiske imidodisulfamider.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
ATE74505T1 (de) Schmerzpraeparat.

Legal Events

Date Code Title Description
FG Grant or registration